We are live on ! Find out more
BSX icon

Boston Scientific

1,643 hedge funds and large institutions have $135B invested in Boston Scientific in 2025 Q1 according to their latest regulatory filings, with 230 funds opening new positions, 667 increasing their positions, 553 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

215% more first-time investments, than exits

New positions opened: 230 | Existing positions closed: 73

31% more call options, than puts

Call options by funds: $1.07B | Put options by funds: $819M

31% more funds holding in top 10

Funds holding in top 10: 3951 (+12)

21% more repeat investments, than reductions

Existing positions increased: 667 | Existing positions reduced: 553

12% more capital invested

Capital invested by funds: $120B → $135B (+$14.8B)

9% more funds holding

Funds holding: 1,5131,643 (+130)

0.19% less ownership

Funds ownership: 90.98%90.79% (-0.19%)

Holders
1,643
Holders Change
+130
Holders Change %
+8.59%
% of All Funds
22.03%
Holding in Top 10
51
Holding in Top 10 Change
+12
Holding in Top 10 Change %
+30.77%
% of All Funds
0.68%
New
230
Increased
667
Reduced
553
Closed
73
Calls
$1.07B
Puts
$819M
Net Calls
+$256M
Net Calls Change
+$371M
Name Holding Trade Value Shares
Change
Change in
Stake
KIA
901
KCM Investment Advisors
California
$913K -$403 -4 -0%
CP
902
Clarendon Private
Massachusetts
$909K +$115K +1,142 +15%
NA
903
Nottingham Advisors
New York
$908K +$503 +5 +0.1%
CCP
904
Clough Capital Partners
Massachusetts
$908K
PCM
905
Penserra Capital Management
California
$888K +$499K +4,952 +128%
OIAM
906
OFI Invest Asset Management
France
$887K +$957K +9,500 New
SAI
907
Savvy Advisors Inc
New York
$883K -$252K -2,506 -22%
SCI
908
Stableford Capital II
Arizona
$882K -$302 -3 -0%
TCA
909
Transcend Capital Advisors
New Jersey
$879K +$128K +1,275 +17%
AIM
910
Aspen Investment Management
Michigan
$878K +$151K +1,497 +21%
PPWP
911
Premier Path Wealth Partners
New Jersey
$878K +$906 +9 +0.1%
CI
912
CX Institutional
Indiana
$877K -$156K -1,550 -15%
WR
913
WD Rutherford
Oregon
$871K +$362K +3,599 +64%
RWB
914
RMR Wealth Builders
New Jersey
$871K -$20.9K -208 -2%
GS
915
GTS Securities
New York
$865K +$9.06K +90 +1%
GI
916
GLOBALT Investments
Georgia
$864K -$78.6K -781 -8%
GC
917
Grimes & Company
Massachusetts
$864K -$441K -4,381 -34%
WT
918
Washington Trust
Rhode Island
$864K
AIA
919
Armor Investment Advisors
North Carolina
$862K
BWP
920
BSW Wealth Partners
Colorado
$855K +$56.3K +559 +7%
JIC
921
Johnson Investment Counsel
Ohio
$850K -$67K -665 -7%
BTD
922
BankPlus Trust Department
Mississippi
$847K +$15.8K +157 +2%
VA
923
VestGen Advisors
Illinois
$839K +$838K +8,318 New
HSA
924
HBK Sorce Advisory
Pennsylvania
$836K +$25.6K +254 +3%
CBT
925
Central Bank & Trust
Kentucky
$831K +$830K +8,242 New

BSX Hedge Fund Activity: Q1 2025 in Review

1,643 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2025, worth a combined $135B — up 12% from $120B a quarter earlier.

Buyers outnumbered sellers: 230 funds opened new BSX positions and 73 closed out — a net gain of 157 holders — while 667 added to existing stakes and 553 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $532M. The largest seller was Franklin Resources, cutting an estimated $915M.

  • 1,643 institutional investors held Boston Scientific (BSX) as of Q1 2025, up from 1,513 in Q4 2024.
  • Funds reported $135B of Boston Scientific stock for Q1 2025, up 12% quarter-over-quarter.
  • 230 funds opened new Boston Scientific positions in Q1 2025 and 73 closed out, a net change of +157 holders.
  • The largest Boston Scientific buyer in Q1 2025 was JP Morgan Chase, an estimated $532M added.
  • The largest Boston Scientific seller in Q1 2025 was Franklin Resources, an estimated $915M sold.

Based on aggregated 13F filings for Q1 2025.